Search for: "EMD, INC."
Results 41 - 50
of 50
Sort by Relevance
|
Sort by Date
2 Jul 2013, 1:41 pm
The other day, I was blogging about tags, and somebody asked what are all the tags. [read post]
13 Jun 2012, 6:22 pm
Mark Halligan, Partner, Nixon Peabody LLP and Thomas Kelley, Consulting Patent Counsel, Monsanto Company Speaker: Jason Duncan, Associate General Counsel, EMD, Serono, Inc. [read post]
1 Jun 2012, 7:20 am
" EMD Crop Bioscience Inc. v. [read post]
7 Nov 2011, 8:07 am
" EMD Crop Bioscience Inc., et. al. v. [read post]
18 May 2011, 4:46 am
Pharmaceutical manufacturers Serono Laboratories, Inc., EMD Serono, Inc., Merck Serono S.A., and Ares Trading S.A., have agreed to pay $44.3 million to resolve False Claims Act allegations in connection with the marketing of the drug Rebif. [read post]
5 May 2011, 2:57 pm
Pharmaceutical giants: Serono Laboratories Inc., EMD Serono Inc., Merck Serono S.A, and Ares Trading S.A. have agreed to settle False Claims Act allegations in connection with the marketing of the drug Rebif for $44.3 million, according to a recent announcement by the Department of Justice. [read post]
4 May 2011, 6:14 am
According to DOJ’s press release: P harmaceutical manufacturers Serono Laboratories Inc., EMD Serono Inc., Merck Serono S.A, and Ares Trading S.A. have agreed to pay $44.3 million to resolve False Claims Act allegations in connection with the marketing of the drug Rebif, the Justice Department announced. [read post]
10 Jun 2010, 3:58 am
EMD Serono, Inc. et al. [read post]
9 Oct 2009, 12:55 pm
On September 28, 2009, the Ontario Securities Commission issued its passport decision In the Matter of National Instrument 31-103 Registration Requirements and Exemptions (NI 31-103 or the Instrument) and Crosbie & Company Inc. and Certain Other Limited Market Dealers that have become Exempt Marker Dealers under Subsection 16.3(2) of NI 31-103 (the Decision). [read post]
19 Feb 2009, 2:46 pm
At the recommendation of Health Canada, EMD Serono Canada Inc. has suspended the marketing of Raptiva in Canada due to safety concerns, including the increased risk of developing PML. [read post]
